2m 2m 2m 2m 2m 2m 2m
LIPOCINE (LPCN)
NASDAQ
$2.25-$0.02 (-1.10%)
Price as of Sep 11, 2026 4:10 PM EDT- $18.7MMarket Cap
- -23.71%1-Year Change
- BiotechnologyIndustry
LIPOCINE (LPCN)
$2.25-$0.02 (-1.10%)
LPCN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.27 | ||
Change | +$0.02 (+0.89%) | ||
Open | $2.29 | ||
High | $2.30 | ||
Low | $2.25 | ||
Previous Close | $2.25 | ||
Volume | 10,397 | ||
30-Day Average Volume | 27,980 | ||
1-Week Change | -7.35% | ||
1-Month Change | 8.61% | ||
1-Year Change | -23.71% | ||
3-Year Change | -39.47% | ||
5-Year Change | -88.96% | ||
Fundamentals | |||
Shares Outstanding | 8.2M | ||
Total Assets | $23.8M | ||
Market Cap | $18.7M | ||
Enterprise Value | $13.7M | ||
Period: QTR TTM FY | |||
Revenue | $190,099.00 | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$3.0M | ||
EBIT | -$2.6M | ||
EBITDA | -$2.6M | ||
Net Working Capital | $21.7M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 72 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 17 | ||
Last Split Date | 05/12/2023 | ||
Earnings & Revenue